# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105468
Filing Date
2025-08-08
Accepted
2025-08-08 07:15:49
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rptx-20250630.htm iXBRL | 10-Q | 2764576
2 | EX-10.1 | rptx-ex10_1.htm | EX-10.1 | 164911
3 | EX-10.2 | rptx-ex10_2.htm | EX-10.2 | 70281
4 | EX-31.1 | rptx-ex31_1.htm | EX-31.1 | 17136
5 | EX-32.1 | rptx-ex32_1.htm | EX-32.1 | 9841
6 | GRAPHIC | img46999202_0.jpg | GRAPHIC | 16694
7 | GRAPHIC | img195065743_0.jpg | GRAPHIC | 49567
| Complete submission text file | 0000950170-25-105468.txt |  | 11363569

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rptx-20250630.xsd | EX-101.SCH | 1204542
80 | EXTRACTED XBRL INSTANCE DOCUMENT | rptx-20250630_htm.xml | XML | 2429050

Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39335 | Film No.: 251196191
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)